Plandaí Biotechnology Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Roger Baylis-Duffield

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	25.3yrs
CEO ownership	n/a
Management average tenure	9.1yrs
Board average tenure	14.2yrs

Recent management updates

No updates

Recent updates

CEO

Roger Baylis-Duffield (82 yo)

25.3yrs

Tenure

US$5,305,000

Compensation

Mr. Roger Baylis-Duffield served as Chairman of the Board and President at Protext Pharma, Inc. (FKA-Protext Mobility). He was Chief Executive Officer of Protext Pharma, Inc. (FKA-Protext Mobility). since...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Roger Baylis-Duffield	Co-Founder	25.3yrs	US$5.31m	no data
Callum Baylis-Duffield	President	9.1yrs	US$382.50k	no data
Ezra Jones	Vice President of Sales and Marketing	9yrs	no data	no data

9.1yrs

Average Tenure

Experienced Management: PLPL's management team is seasoned and experienced (9.1 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Roger Baylis-Duffield	Co-Founder	no data	US$5.31m	no data
Callum Baylis-Duffield	President	13.2yrs	US$382.50k	no data
Daron Duffield	Co-Founder & Director	no data	US$45.00k	no data
Thomas Matula	Chairman of the Scientific Board	14.3yrs	US$1.94m	no data
Volker Boehm	Member of Scientific Board	14.2yrs	no data	no data

14.2yrs

Average Tenure

69yo

Average Age

Experienced Board: PLPL's board of directors are seasoned and experienced ( 14.2 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/04/23 22:26
End of Day Share Price	2026/04/21 00:00
Earnings	2016/09/30
Annual Earnings	2016/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Plandaí Biotechnology, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.